Human milk oligosaccharide: Difference between revisions
Content deleted Content added
Snazzywiki (talk | contribs) m removing a category that really isn't applicable |
Snazzywiki (talk | contribs) m re-ordering sections for a more logical flow |
||
| Line 1: | Line 1: | ||
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycans that are found in and unique to human breast milk, despite not actually being digestible by human infants.<ref name="HMO-EVOLUTION">{{cite journal |last=German |first=JB |last2=Lebrilla |first2=CB |last3=Mills |first3=DA |date=18 Apr 2012 |title=Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria |url=http://www.ncbi.nlm.nih.gov/pubmed/18626202 |journal=Nestle Nutr Workshop Ser Pediatr Program |publisher= |volume=62 |issue= |pages=205-22 |doi=10.1159/000146322 |pmid=18626202 |access-date=}}</ref> HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.<ref name="BODE-L-GLYCOBIOLOGY">{{cite journal |last=Bode |first=L |last2= |first2= |date=18 Apr 2012 |title=Human milk oligosaccharides: every baby needs a sugar mama |url=http://www.ncbi.nlm.nih.gov/pubmed/22513036 |journal=[[Glycobiology (journal)|Glycobiology]] |publisher= |volume=22 |issue=9 |pages=1147–62 |doi=10.1093/glycob/cws074 |pmid=22513036 |access-date=}}</ref> |
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycans that are found in and unique to human breast milk, despite not actually being digestible by human infants.<ref name="HMO-EVOLUTION">{{cite journal |last=German |first=JB |last2=Lebrilla |first2=CB |last3=Mills |first3=DA |date=18 Apr 2012 |title=Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria |url=http://www.ncbi.nlm.nih.gov/pubmed/18626202 |journal=Nestle Nutr Workshop Ser Pediatr Program |publisher= |volume=62 |issue= |pages=205-22 |doi=10.1159/000146322 |pmid=18626202 |access-date=}}</ref> HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.<ref name="BODE-L-GLYCOBIOLOGY">{{cite journal |last=Bode |first=L |last2= |first2= |date=18 Apr 2012 |title=Human milk oligosaccharides: every baby needs a sugar mama |url=http://www.ncbi.nlm.nih.gov/pubmed/22513036 |journal=[[Glycobiology (journal)|Glycobiology]] |publisher= |volume=22 |issue=9 |pages=1147–62 |doi=10.1093/glycob/cws074 |pmid=22513036 |access-date=}}</ref> |
||
| ⚫ | |||
| ⚫ | In experiments designed to test the suitability of HMOs as a prebiotic source of carbon for intestinal bacteria it was discovered that they are highly selective for a commensal bacteria known as ''[[Bifidobacterium longum|Bifidobacteria longum biovar infantis]]''. The presence of genes unique to ''[[Bifidobacterium longum|B. infantis]]'', including co-regulated glycosidases, and its efficiency at using HMOs as a carbon source may imply a co-evolution of HMOs and the genetic capability of select bacteria to utilize them.<ref name="HMO-EVOLUTION"></ref> |
||
==Other biological roles== |
==Other biological roles== |
||
HMOs have been implicated in modulating responses of the epithelium and of the immune cells, reducing excessive mucosal leukocyte infiltration and activation, and lowering the risk for necrotizing enterocolitis and possibly also providing the infant with sialic acid as a potentially essential nutrient for brain development and cognition.<ref name="BODE-L-GLYCOBIOLOGY"></ref> |
HMOs have been implicated in modulating responses of the epithelium and of the immune cells, reducing excessive mucosal leukocyte infiltration and activation, and lowering the risk for necrotizing enterocolitis and possibly also providing the infant with sialic acid as a potentially essential nutrient for brain development and cognition.<ref name="BODE-L-GLYCOBIOLOGY"></ref> |
||
| ⚫ | |||
| ⚫ | In experiments designed to test the suitability of HMOs as a prebiotic source of carbon for intestinal bacteria it was discovered that they are highly selective for a commensal bacteria known as ''[[Bifidobacterium longum|Bifidobacteria longum biovar infantis]]''. The presence of genes unique to ''[[Bifidobacterium longum|B. infantis]]'', including co-regulated glycosidases, and its efficiency at using HMOs as a carbon source may imply a co-evolution of HMOs and the genetic capability of select bacteria to utilize them.<ref name="HMO-EVOLUTION"></ref> |
||
==References== |
==References== |
||
Revision as of 00:17, 23 December 2015
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycans that are found in and unique to human breast milk, despite not actually being digestible by human infants.[1] HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.[2]
Other biological roles
HMOs have been implicated in modulating responses of the epithelium and of the immune cells, reducing excessive mucosal leukocyte infiltration and activation, and lowering the risk for necrotizing enterocolitis and possibly also providing the infant with sialic acid as a potentially essential nutrient for brain development and cognition.[2]
Evolution
In experiments designed to test the suitability of HMOs as a prebiotic source of carbon for intestinal bacteria it was discovered that they are highly selective for a commensal bacteria known as Bifidobacteria longum biovar infantis. The presence of genes unique to B. infantis, including co-regulated glycosidases, and its efficiency at using HMOs as a carbon source may imply a co-evolution of HMOs and the genetic capability of select bacteria to utilize them.[1]
References
- ^ a b German, JB; Lebrilla, CB; Mills, DA (18 Apr 2012). "Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria". Nestle Nutr Workshop Ser Pediatr Program. 62: 205–22. doi:10.1159/000146322. PMID 18626202.
- ^ a b Bode, L (18 Apr 2012). "Human milk oligosaccharides: every baby needs a sugar mama". Glycobiology. 22 (9): 1147–62. doi:10.1093/glycob/cws074. PMID 22513036.